Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Recruiting4
Other4

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT07905066Recruiting
Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell Transplantation
Hemophagocytic Lymphohistiocytosis (HLH)
PrincipalinvestigatorStart date: 2026-10-19
NCT07569055Recruiting
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Invasive Fungal Disease
PrincipalinvestigatorStart date: 2025-03-15
NCT06727669Recruiting
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Arterial ThromboembolismBleeding DisorderCoagulation Factor Deficiency+13 more
PrincipalinvestigatorStart date: 2024-11-01
NCT06176911Phase 2Unknown
The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
Immune Thrombocytopenia
PrincipalinvestigatorStart date: 2023-12-05
NCT07068425Not Yet Recruiting
Longitudinal Observational Study on Immune Thrombocytopenia
Immune Thrombocytopenia (ITP)
Principalinvestigator
NCT07113730Not Yet Recruiting
The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes
Chronic Myelomonocytic Leukemia (CMML)Immune Reconstitution
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ellis Neufeld, MD

Boston Children's Hospital

Related
6 trials

Shared therapeutic areas:

Hemophilia APurpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic Thrombocytopenic
Similarity Score4%

lei zhang, MD

Chinese Academy of Medical Science and Blood Disease Hospital

Related
19 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicHemophilia AImmune Thrombocytopenia (ITP)
Similarity Score4%

Thomas Ortel, MD

Duke University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic Thrombocytopenic
Similarity Score3%

Joseph Kiss, MD

University of Pittsburgh

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic Thrombocytopenic
Similarity Score3%

David Kuter, MD

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic Thrombocytopenic
Similarity Score3%

Cindy Leissinger, MD

Tulane University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic Thrombocytopenic
Similarity Score3%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Pulmonary EmbolismDeep Vein Thrombosis
Similarity Score3%

Karin BILGER, MD

Hôpital de Haute-Pierre, Strasbourg

Related
1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic
Similarity Score1%

Marie-Christine THOURET, MD

CHU de l'Archet 2, Nice

Related
1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic
Similarity Score1%

Hubert NIVET, MD, PhD

Hôpital Gatien de Clovheville, Tours

Related
1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT07905066PrincipalInvestigator

Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell Transplantation

Hemophagocytic Lymphohistiocytosis (HLH)
Recruiting
NCT07065968Phase 2PrincipalInvestigator

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

Immune Thrombocytopenia (ITP)
Recruiting
NCT07569055PrincipalInvestigator

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Invasive Fungal Disease
Recruiting
NCT06727669PrincipalInvestigator

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Arterial ThromboembolismBleeding DisorderCoagulation Factor Deficiency+13 more
Recruiting
NCT06176235Phase 2PrincipalInvestigator

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Immune Thrombocytopenia
Withdrawn
NCT06176911Phase 2PrincipalInvestigator

The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Immune Thrombocytopenia
Unknown
NCT07068425PrincipalInvestigator

Longitudinal Observational Study on Immune Thrombocytopenia

Immune Thrombocytopenia (ITP)
Not Yet Recruiting
NCT07113730PrincipalInvestigator

The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes

Chronic Myelomonocytic Leukemia (CMML)Immune Reconstitution
Not Yet Recruiting

All 8 trials loaded